Results 121 to 130 of about 37,130 (197)

Incidence and characteristics of eravacycline-associated increase in serum bilirubin levels: a retrospective study. [PDF]

Front Pharmacol
Si Y, Chen M, Zhang J, Jiang J, Zhang Y, Yu G, Guo N, Yan G, Leng B.   +8 more
europepmc   +1 more source

First co-emergence of plasmid-borne tigecycline resistance genes <i>tet</i>(X4) and <i>tmexCD1-toprJ1</i> in <i>Raoultella ornithinolytica</i> isolated from retail pork: insights from global genomic analysis. [PDF]

Curr Res Food Sci
Shoaib M, Munir A, Hameed MF, Zeb S, Li Z, Peng K, Shah N, Butaye P, Wang Z, Li R.   +9 more
europepmc   +1 more source

Phenotypic and genomic characterization of tigecycline heteroresistance in carbapenem-resistant <i>Klebsiella pneumoniae</i>. [PDF]

Microbiol Spectr
Tao X, Xia Y, Zhong L.
europepmc   +1 more source

Case Report: Rare Multidrug-Resistant Enterobacter Cloacae Complicated by Invasive Pulmonary Aspergillosis in an Elderly Patient with Advanced Lung Adenocarcinoma Treated with Osimertinib. [PDF]

Infect Drug Resist
Zhou M, Shi J, Cao C, Zhang C.
europepmc   +1 more source

The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis [PDF]

, 2017

core   +1 more source

Prevalence Trends and Antimicrobial Resistance of Carbapenem-Resistant Gram-Negative Bacteria in Paediatric Patients in Sichuan Province: A Retrospective Study (2021-2025). [PDF]

Infect Drug Resist
You Z, Huang X, Liu X, Yu H, Long S.
europepmc   +1 more source

Transient AdeABC-mediated eravacycline resistance in carbapenem-resistant Acinetobacter baumannii ST2: a mutation-independent efflux pump adaptation. [PDF]

Ann Clin Microbiol Antimicrob
Yang X, He N, Haque A, Mai Y, Wang J, Xiao S, Zhuo C.   +6 more
europepmc   +1 more source

Prevalence of ESBL-producing Escherichia coli from different canine populations in Italy [PDF]

, 2016
DOTTO, GIORGIA, MARTINI, MARCO, MENANDRO, MARIA LUISA, MONDIN, ALESSANDRA, PASOTTO, DANIELA, Tonellato, F. R.   +5 more
core   +1 more source

Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration. [PDF]

Eur J Hosp Pharm
Chen F, Ding H, Liu S, Chen Z, Tang L, Tong T.   +5 more
europepmc   +1 more source

Residual confounding and outcome definition in observational comparisons of PDR-<i>Acinetobacter baumannii</i> therapies. [PDF]

Antimicrob Agents Chemother
Külls C, Dadashpour N, Golestanieraghi M.   +2 more
europepmc   +1 more source